Home » Topics » Regulatory » Patents

Patents
RSS

Novel antidepressants from SB act on multiple 5-HT receptor subtypes

July 7, 1999

New purine PDE4 inhibitors from Mitsubishi useful for asthma Rx

July 7, 1999

Dual-acting piperazines inhibit TNF-alpha production, stimulate IL-10 production

July 7, 1999

Yamanouchi prepares selective inhibitors of Ca2+ release-activated Ca2+ channels (CRACC)

July 7, 1999

Non-thiol-containing peptidomimetic protein farnesyltransferase inhibitors from Merck

July 7, 1999

Inhibitors of key enzyme in kynurenine metabolic pathway designed at Pharmacia & Upjohn

July 7, 1999

Expectorants developed at Sawai more effective than ambroxol in animal model

July 6, 1999

LG Chemical presents wide series of imidazoles useful as inhibitors of protein farnesyltransferase

July 6, 1999

Novel glycoside antithrombotic agents in the pipeline at Gedeon Richter

July 6, 1999

Search for therapeutically effective protein farnesyltransferase inhibitors continues at Merck

July 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...